Albert Ludolph

Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study

Gilbert Bensimon, Albert Ludolph, Yves Agid et al. · Brain · 2008 · 346 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +17

Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

Katrina Moore, Jennifer Nicholas, Murray Grossman et al. · The Lancet Neurology · 2019 · 311 citations · Full text

Medicine, Genetics, Neurology +17

Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial

Adam L. Boxer, Anthony E. Lang, Murray Grossman et al. · The Lancet Neurology · 2014 · 289 citations · Full text

Medicine, Neurology, Pharmacotherapy +5

Genetic Variants of the α-Synuclein Gene SNCA Are Associated with Multiple System Atrophy

Ammar Al‐Chalabi, Alexandra Dürr, Nicholas Wood et al. · PLoS ONE · 2009 · 196 citations · Full text

Life Sciences, Genetics, Neurology +17

Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial

Günter U. Höglinger, Irene Litvan, Nuno Mendonça et al. · The Lancet Neurology · 2021 · 138 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +4